Regulating Bone Growth and Development with Bone Morphogenetic Proteins

Abstract:  There are many gene products reported to promote osteoblast differentiation and thus increase bone formation, but only the transcription factor Runx2 and members of the bone morphogenetic protein (BMP) family of growth/differentiation factors have been shown to be absolute requirements for osteogenesis. Mice lacking the transcription factor Runx2 (also known as cbfa1) develop no bone. Similarly, osteoblast differentiation and bone formation is blocked when BMP signaling is suppressed by overexpression of noggin, a selective BMP antagonist. It is therefore not unexpected that several different mechanisms have evolved to regulate the effects of BMP‐induced signaling. In this session we focus on the multiple ways in which cells can modulate BMP‐induced osteogenesis and mechanisms by which BMP signaling can lead to transcriptional control of gene expression.

[1]  H. Beppu,et al.  Bone Morphogenetic Protein (BMP) Type II Receptor Deletion Reveals BMP Ligand-specific Gain of Signaling in Pulmonary Artery Smooth Muscle Cells* , 2005, Journal of Biological Chemistry.

[2]  Ken W. Y. Cho,et al.  Phylogenetic footprinting and genome scanning identify vertebrate BMP response elements and new target genes. , 2005, Developmental biology.

[3]  Xu Cao,et al.  BMP signaling in skeletal development. , 2005, Biochemical and biophysical research communications.

[4]  E. Schipani,et al.  Molecular mechanisms of endochondral bone development. , 2005, Biochemical and biophysical research communications.

[5]  Tatsuya Kobayashi,et al.  Minireview: transcriptional regulation in development of bone. , 2005, Endocrinology.

[6]  J. Saint-Jeannet,et al.  Induction of the neural crest and the opportunities of life on the edge. , 2004, Developmental biology.

[7]  C. Niehrs,et al.  Transcriptional regulation of BMP4 synexpression in transgenic Xenopus , 2004, The EMBO journal.

[8]  M. Goumans,et al.  Controlling cell fate by bone morphogenetic protein receptors , 2003, Molecular and Cellular Endocrinology.

[9]  J. Lemonnier,et al.  Activation of p38 Mitogen‐Activated Protein Kinase and c‐Jun‐NH2‐Terminal Kinase by BMP‐2 and Their Implication in the Stimulation of Osteoblastic Cell Differentiation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  T. Blunk,et al.  Bone Morphogenetic Protein 9: A Potent Modulator of Cartilage Development In Vitro , 2003, Growth factors.

[11]  Anja Nohe,et al.  The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[12]  X. Cao,et al.  Smad1 Domains Interacting with Hoxc-8 Induce Osteoblast Differentiation* , 2000, The Journal of Biological Chemistry.

[13]  V. Gino.  MOLECULAR MECHANISMS OF ENDOCHONDRAL BONE FORMATION , 1998 .

[14]  V. Rosen,et al.  Novel regulators of bone formation: molecular clones and activities. , 1988, Science.

[15]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[16]  J. Szatkowski,et al.  Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). , 2003, The Journal of bone and joint surgery. American volume.

[17]  K. Lyons,et al.  Bone morphogenetic protein-3 is a negative regulator of bone density , 2001, Nature Genetics.